COVID-19 Diagnosis, Oral Anticoagulation, and Stroke Risk in Patients with Atrial Fibrillation

Yang L, Tang S, Guo J, Gabriel N, Gellad WF, Essien UR, Magnani JW, Hernandez I. COVID-19 Diagnosis, Oral Anticoagulation, and Stroke Risk in Patients with Atrial Fibrillation. Am J Cardiovasc Drugs. 2024 Aug 13. doi: 10.1007/s40256-024-00671-3. Epub ahead of print. PMID: 39136872.


Related Posts

William J. Carroll, MD
Joshua N. Khalili, MD Appointed to DoM Chief Wellness Officer featured image
Sun M. Yoo, MD, MPH to Depart DoM to Pursue New Leadership Opportunity featured image